US Stock MarketDetailed Quotes

GRCE Grace Therapeutics

Watchlist

2.280
-0.040-1.72%

Close Mar 31 16:00 ET

2.280
0.0000.00%

Post 16:05 ET

31.28MMarket Cap-1.98P/E (TTM)

Grace Therapeutics Stock Forum

Jaguar8

Mar 28 06:17

🟠Watchlist, MARCH 28,2025, Friday. NFA - DrJag8

NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If y...

Jaguar8

Mar 27 06:55

⚫️Watchlist, MARCH 27,2025, Thursday. NFA -DrJag8

Teddy123

Feb 13 21:19

Grace Therapeutics Announces Third Fiscal Quarter 2025 Financial Results, Provides Business Update

$Grace Therapeutics (GRCE.US)$
Stock Market News Today

Trytosaveabit

Feb 10 21:12

news

$Grace Therapeutics (GRCE.US)$ Press Release: Grace Therapeutics Announces Private Placement Financing of up to $30 Million
Dow Jones· 6 mins ago

Teddy123

Feb 10 21:09

Grace Therapeutics Announces Results From Pivotal Phase 3 STRIVE-ON Safety Trial of GTx-104 in aSAH

$Grace Therapeutics (GRCE.US)$
Grace's GTx-104 Clinical Data Reveals Major Breakthrough for Brain Hemorrhage Treatment

Jaguar8

Feb 10 21:03

NEWS

$Grace Therapeutics (GRCE.US)$
Grace Therapeutics Announces Results From Pivotal Phase 3 STRIVE-ON Safety Trial of GTx-104 in aSAH
Monday, 10th February at 8:01 am
Trial Met the Primary Endpoint and Provides Evidence of GTx-104 Clinical Benefit Compared to Orally Administered Nimodipine
New Drug Application (NDA) Submission Expected in the First Half of 2025
PRINCETON, N.J., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (NASDAQ: GRCE), formerly Acasti Pharma Inc. (Grace Therapeut...

No comment yet

GRCE Grace Therapeutics

Grace Therapeutics Stock Forum

Market Insights